Journal profile · Immunology
Inflammation Research
ISSN 1023-3830 · eISSN 1420-908X · Springer International Publishing · SWITZERLAND · Monthly · Founded 1969
Inflammation Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.16; hybrid open access; APC about USD 4,790; median 100 days to acceptance (105 articles, last 24 months); community-reported acceptance: easy; 186 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Inflammation Research is published by Springer International Publishing and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mast cells and histamine, Asthma and respiratory diseases and Immune Response and Inflammation, together about 32.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Inflammation Research (IR) publishes peer-reviewed papers on all aspects of inflammation and related fields including histopathology, immunological mechanisms, gene expression, mediators, experimental models, clinical investigations and the effect of drugs. Related fields are broadly defined and include for instance, allergy and asthma, shock, pain, joint damage, skin disease as well as clinical trials of relevant drugs. Bibliographic DataFirst published in 1969Renamed in 19951 volume per year, 12 issues per volume+ 2 supplements, in free sequenceFormat: 21 x 27.9 cmISSN 1023-3830 (print)ISSN 1420-908X (electronic)
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief John A. Di BattistaPublisher website
Editorial board by country: none in mainland China; most named United States 4, United Kingdom 4, Canada 4, Japan 1, Germany 1 (18 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mast cells and histamineImmunology and Microbiology16%
- Asthma and respiratory diseasesMedicine8.5%
- Immune Response and InflammationImmunology and Microbiology7.8%
- Inflammatory mediators and NSAID effectsMedicine6.6%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology6.2%
- Polyamine Metabolism and ApplicationsBiochemistry, Genetics and Molecular Biology6.1%
- Neuropeptides and Animal PhysiologyNeuroscience4.9%
- Coagulation, Bradykinin, Polyphosphates, and AngioedemaMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.16LetPub ·
- Impact factor (publisher) 2025
- 6.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.2Publisher website ·
- CiteScore 2026-06
- 9.5LetPub ·
- SJR 2026-06
- 1.55LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 82LetPub ·
- h-index
- 138OpenAlex ·
- i10-index
- 4,415OpenAlex ·
- 2-year mean citedness
- 4.96OpenAlex ·
- Self-citation rate
- 1.6%LetPub ·
- Share of gold OA articles
- 22.02%LetPub ·
Volume
- Articles per year
- 179LetPub ·
- Downloads per year (publisher) 2025
- 909,700Publisher website ·
Articles by year OpenAlex count · 9,108 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 220 | 69 | 147 |
| 2025 | 186 | 45 | 905 |
| 2024 | 131 | 36 | 1,611 |
| 2023 | 145 | 46 | 2,532 |
| 2022 | 151 | 63 | 3,732 |
| 2021 | 101 | 34 | 2,801 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
100 daysMedian, submission to acceptance · P25–P75 78 days – 122 days
- Acceptance to online
- median 23 days (105 articles)
- Submission to online
- median 129 days
- Sample
- 105 articles with submission and acceptance dates (199 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,790 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- 150–200 words
- Keywords
- ≥ 4
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Optional
- Not considered
- preliminary or screening data
Article types accepted3
- editorialWe use electronic forms of all articles during submission and typesetting. Manuscripts received are acknowledged immediately. Manuscripts will be assessed by tw…Length not stated
- original researchGeneral RemarksAll pages should be numbered consecutively, including references, tables and figure legends. All text, including figure legends, tables and refer…Length not stated
- reviewGeneral RemarksAll pages should be numbered consecutively, including references, tables and figure legends. All text, including figure legends, tables and refer…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein.
Source ↗Publisher website ·- Authorship Authorship Policy
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories: • Conceived of or designed study • Performed research • Analyzed data • Contributed new methods or models • Wrote the paper Back to top
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Inflammation Research, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1969
- ISSN
- 1023-3830
- Electronic ISSN
- 1420-908X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Inflammation Research
What CAS zone is Inflammation Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Inflammation Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Inflammation Research?
The latest impact factor listed by LetPub is 6.16; CiteScore 9.5, h-index 138.
How long does peer review take at Inflammation Research?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 78–122 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Inflammation Research?
According to the journal's author guidelines: Abstract: 150–200 words; Keywords: ≥ 4; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Inflammation Research based?
Of the 18 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4), United Kingdom (4) and Canada (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Inflammation Research?
According to LetPub and DOAJ records, Inflammation Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Inflammation Research open access, and what is the APC?
Inflammation Research is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .